Rhumbline Advisers Oncology Institute, Inc. Transaction History

Rhumbline Advisers

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$0.5 - $1.66 $5,018 - $16,661	-10,037 Reduced 82.19%	2,175 $3,000
Q2 2023 Aug 08, 2023	SELL	$0.35 - $0.72 $9,235 - $18,999	-26,388 Reduced 68.36%	12,212 $6,000
Q1 2023 May 11, 2023	BUY	$0.48 - $1.7 $872 - $3,090	1,818 Added 4.94%	38,600 $26,000
Q4 2022 Feb 14, 2023	BUY	$0.88 - $5.22 $1,015 - $6,023	1,154 Added 3.24%	36,782 $61,000
Q3 2022 Nov 10, 2022	BUY	$0.71 - $7.4 $9,330 - $97,243	13,141 Added 58.44%	35,628 $165,000
Q2 2022 Aug 11, 2022	BUY	$4.78 - $9.89 $107,487 - $222,396	22,487 New	22,487 $114,000

17.5M

Ticker TOI
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 73,495,504
Market Cap $11M
Description
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical tr...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.